Wink, CSD; Meyer, MR; Braun, T; Turcant, A; Maurer, HH. Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS n , and LC-high-resolution-MS n Anal. Bioanal. Chem., 1 Jan 2015, 407 (3), 831–843. 1.8 MB. https://doi.org/10.1007/s00216-014-8083-2 #13 GC,LC,MS
N-(2-Methoxyethyl)-3,4-methylenedioxyamphetamine · N-Methoxyethyl-MDA · MDMEOET
4-Acetyl-2,5-dimethoxyamphetamine · DOAC
N-Me-2,5-DEPEA-βk · β-Keto-N-methyl-2,5-diethoxyphenethylamine
2,5-DEA-βk · 2,5-Diethoxycathinone
5,6,7-Trimethoxy-2-aminotetralin · TMAT
Gigantine (Earlier, incorrect structure)
4-Cyclopropoxy-3,5-dimethoxyphenethylamine · 4-cPrO-3,5-DMPEA · CP · Cycloproscaline
2,5-DMA-Ac · N-Acetyl 2,5-DMA · N-Acetyl 2,5-dimethoxyamphetamine
4-Allyloxy-2,6-dimethoxyphenethylamine · ψ-2C-O-16
2C-O-16 · 4-Allyloxy-2,5-dimethoxyphenethylamine
2,5-Dimethoxy-4-(oxetan-3-yl)phenethylamine · 2C-OXET3
5-Ac-DOM · 5-Acetoxy-2 methoxy-4-methylamphetamine
bk-2C-P · β-Keto-2,5-dimethoxy-4-propylphenethylamine
bk-2C-iP · β-Keto-4-isopropyl-2,5-dimethoxyphenethylamine
bk-MDOM · β-Keto-N-methyl-2,5-dimethoxy-4-methylamphetamine
2,5-Dimethoxy-4-(oxetan-2-yl)phenethylamine · 2C-OXET-2